Large platform vs smaller platform
Gala vs TMates: Track Record and Scale Compared (2026)
Gala or TMates? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Gala and TMates side by side and the marketing reads almost identically. The programs underneath do not.
One of these has been through the operational grind at scale and one is earlier in that curve: 21,970 reviews at TMates, 2,870 at Gala.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest 12-month cost
- Gala — $2,148 against $2,388 at TMates, on each provider's own best published pricing.
- Most predictable bill
- TMates — Flat rate at every dose, so titration does not change what you are charged.
- Quickest to start
- Gala — Fully online, no in-office visits, then home delivery.
- Easiest to pay for
- Gala — Neither publishes financing; both expect the full amount monthly.
The short version: Gala vs TMates
The rows below are the ones that differ enough between these two to be worth your attention.
| Gala | TMates | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | $199/mo at every dose, no step-up fees |
| Rate after promotions | $249/mo | $199/mo |
| Pricing structure | Cheaper per month the longer you commit | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | Fully online, no in-office visits | Virtual check-in appointments |
| State coverage | Not published | All 50 states |
| Patient reviews | 2,870 | 21,970 |
| eRxDoctor score | 7.7/10 | 7.0/10 |
What Gala and TMates actually cost over a year
Comparing entry prices across these two would be actively misleading, because they escalate differently. The totals below are the honest version, built from the rates each provider publishes.
| Gala | TMates | |
|---|---|---|
| First month | $249 | $199 |
| Months 2 onward | $249/mo | $199/mo |
| 6-month total | $1,494 | $1,194 |
| 12-month total | $2,988 | $2,388 |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | No multi-month discount published |
Gala finishes the year $240 cheaper. For some patients the support TMates bundles closes that gap; for a patient who only needs the prescription written, it does not.
Track record, and what review volume is worth
TMates has 21,970 reviews on record against 2,870 for Gala. Star ratings sit close together across this whole market, so the count is more informative than the score: it tells you how many times the operation has been tested.
Scale matters in this category for unglamorous reasons — pharmacy relationships that hold when demand spikes, support that answers on a Sunday, and a refund process that exists. Gala may run all of that well; there is simply less public evidence either way, and there is the standing caveat that the entry price sits above most compounded competitors unless you commit to a longer term.
Weigh the smaller platform on what it publishes rather than what it lacks: a direct-pay model with dose monitoring included rather than sold as an add-on.
How Gala works
The pitch is a direct-pay model with dose monitoring included rather than sold as an add-on. Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery.
You start with fully online, no in-office visits; medication arrives via home delivery. The price behaves as cheaper per month the longer you commit.
Ongoing care is provider check-ins and dose monitoring included, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Gala pros
- Direct-pay model, no insurance or prior authorizations needed
- Provider check-ins and dose monitoring included
- Fully online, no in-office visits required
Gala cons
- Lower long-term pricing requires a multi-month commitment
- Higher entry price than several compounded competitors
The reservation worth holding, particularly next to TMates: the entry price sits above most compounded competitors unless you commit to a longer term.
TMates in detail
$199/month, every dose, no step-up fees
The process is virtual check-in appointments, then medication formulated in U.S. facilities. On money, expect flat rate at every dose — published upfront.
Support: 24/7 access to U.S.-based doctors, not just messaging. The medications on offer are compounded semaglutide.
TMates pros
- 24/7 access to U.S.-based doctors, not just messaging support
- Flat $199/month at every dose, no step-up fees as dosage escalates
- Medications formulated in U.S.-based facilities
- Licensed coverage in all 50 states
TMates cons
- $199/month is higher than the cheapest compounded options
- Compounded semaglutide only, limited public detail on tirzepatide availability
- No branded Ozempic, Wegovy, or Zepbound
Read next to Gala, the weak point: semaglutide only, and $199 is well above the cheapest compounded options.
Gala or TMates: matching the program to the patient
Choose Gala if:
- you want to start on their timeline: fully online, no in-office visits
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- the feature you would actually use: a direct-pay model with dose monitoring included rather than sold as an add-on
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
Choose TMates if:
- the monthly rate is the constraint — $199/mo against $249/mo
- you want the price you sign up at to survive titration
- you would rather use the platform with the longer public record (21,970 reviews)
- you are in a state where GLP-1 telehealth coverage is patchy
The trade-offs, stated plainly
On price. The monthly gap is 25% in TMates's favor. Whether that is a saving or a false economy turns on one thing: semaglutide only, and $199 is well above the cheapest compounded options.
On commitment. Gala rewards a longer commitment (longer-term plan at $179/mo), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — provider check-ins and dose monitoring included against 24/7 access to U.S.-based doctors, not just messaging — and that difference is felt in week two, not week one.
On medication. Gala covers compounded semaglutide and compounded tirzepatide; TMates covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
What the evidence actually says
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Gala vs TMates: common questions
Which is cheaper to start, Gala or TMates?
TMates, at $199 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which has more patient reviews, Gala or TMates?
TMates, with 21,970 against 2,870. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Are Gala and TMates legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Gala operates on cheaper per month the longer you commit with pricing published upfront, TMates on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Is Gala or TMates better for a first GLP-1 prescription?
For a first prescription, weight support over price. Gala offers more contact (provider check-ins and dose monitoring included), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
What happens if I stop taking the medication?
Neither Gala nor TMates penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Do Gala and TMates prescribe the same medication?
Both dispense compounded GLP-1 preparations. Gala lists compounded semaglutide and compounded tirzepatide and TMates lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Can I switch from Gala to TMates later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
The verdict
On the numbers, Gala wins the year: $2,148 against $2,388. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where TMates justifies itself is one flat $199 that survives every titration step, with doctors rather than a message queue behind it. Where it does not is anywhere the extra spend buys features you will never open.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Gala vs He & She MDCoaching-supported vs medication-only
- Gala vs MaximusBudget vs premium
- Mochi Health vs TMatesBudget vs premium
- Elevate Health vs TMatesTirzepatide access
- Novi vs MaximusLarge platform vs smaller platform
- Refills vs NoviLarge platform vs smaller platform
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or TMates, and does not sell treatment. Read our ranking methodology.